Product Information
MINOCYCLINE HCL 50 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.3652 per EA under NDC 59651033701. Its NADAC has been published 254 times since Aug 11, 2021.
FDA first approved this application on May 1, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Minocycline Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651033701
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MINOCYCLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213662FDA Approved
5/1/2020
TE Code
AB
On Market Since
5/1/2020
Pharmacological Classes
Price Statistics
The NADAC for MINOCYCLINE HCL 50 MG TABLET has been published 254 times since Aug 11, 2021, and over the history we have for it it has declined 51.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3652 per EA |
|---|---|
| All-time high | $1.5732 (Apr 13, 2022) |
| All-time low | $0.2336 (Jun 19, 2024) |
| 52-week high | $0.4484 |
| 52-week low | $0.3652 |
| Median price | $0.4223 |
| Average price | $0.5982 |
| Largest weekly change | +109.0% (Feb 23, 2022) |
| Weeks tracked | 254 |
| Tracking since | Aug 11, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MINOCYCLINE HCL 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MINOCYCLINE HCL 50 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.3652 per EA (NDC 59651033701), effective Aug 19, 2026.
How has the price of MINOCYCLINE HCL 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for MINOCYCLINE HCL 50 MG TABLET has declined 51.5%. It has been tracked across 254 weekly CMS publications since Aug 11, 2021.
What are the highest and lowest recorded NADAC prices for MINOCYCLINE HCL 50 MG TABLET?
Since Aug 11, 2021, the NADAC for MINOCYCLINE HCL 50 MG TABLET has ranged from a low of $0.2336 (Jun 19, 2024) to a high of $1.5732 (Apr 13, 2022), with a median of $0.4223 per EA.
Are there cheaper alternatives to MINOCYCLINE HCL 50 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MINOCYCLINE HCL 50 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MINOCYCLINE HCL 50 MG TABLET?
MINOCYCLINE HCL 50 MG TABLET (NDC 59651033701) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.